Voya Investment Management LLC Allovir, Inc. Transaction History

Voya Investment Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$2.15 - $3.64 $9,528 - $16,132	4,432 Added 25.96%	21,504 $46,000
Q2 2023 Aug 14, 2023	BUY	$3.17 - $5.82 $13,396 - $24,595	4,226 Added 32.9%	17,072 $58,000
Q3 2022 Nov 14, 2022	BUY	$4.13 - $8.79 $6,058 - $12,894	1,467 Added 12.89%	12,846 $101,000
Q4 2021 Feb 14, 2022	SELL	$12.94 - $25.99 $3,338 - $6,705	-258 Reduced 2.22%	11,379 $147,000
Q3 2021 Nov 15, 2021	SELL	$16.97 - $25.06 $8,434 - $12,454	-497 Reduced 4.1%	11,637 $292,000
Q2 2021 Aug 16, 2021	SELL	$19.44 - $25.06 $12,130 - $15,637	-624 Reduced 4.89%	12,134 $240,000
Q1 2021 May 17, 2021	BUY	$20.81 - $45.5 $104,050 - $227,500	5,000 Added 64.45%	12,758 $299,000
Q4 2020 Feb 16, 2021	BUY	$23.94 - $46.81 $185,726 - $363,151	7,758 New	7,758 $298,000

44.6M

14.9K

200

Ticker ALVR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,063,400
Market Cap $40.9M
Description
Allovir, Inc., a clinical-stage cell therapy company, engages in the research and development of allogeneic, off-the-shelf multi-virus specific T cell (VST) therapies to prevent and treat devastating viral-associated diseases. The company's lead product is posoleucel, an allogeneic, off-the-shelf VST therapy, to treat BK virus, cytomegalovirus, ...

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Voya Investment Management LLC with notifications on news.